Literature DB >> 29590004

Molecular Mechanisms of Colistin Resistance Among Pandrug-Resistant Isolates of Acinetobacter baumannii with High Case-Fatality Rate in Intensive Care Unit Patients.

Mehri Haeili1, Mahsa Kafshdouz1, Mohammad Mehdi Feizabadi2,3.   

Abstract

Colistin is considered a last-hope antibiotic against extensively drug-resistant isolates of Acinetobacter baumannii. Resistance to colistin has been rarely reported for A. baumannii. Genetic alterations in the PmrA-PmrB two-component system and lipid A biosynthesis genes may be associated with colistin resistance. We investigated molecular mechanisms of colistin resistance in three clinical colistin-resistant (ColR) and two colistin-susceptible (ColS) A. baumannii isolates. A ColR mutant was generated in vitro by repetitive drug exposure. The pmrA, pmrB, lpxA, lpxC, and lpxD genes were amplified and sequenced. To evaluate association between colistin resistance and upregulation of pmrCAB operon, transcriptional level of the pmrC gene encoding for lipid A phosphoethanolamine (PEtN) transferase was quantified by reverse transcription quantitative PCR (RT-qPCR) analysis. All clinical and in vitro-selected ColR isolates harbored at least one point mutation in the pmrB gene, including A142V, P233S, T235I, and A227V substitutions as well as duplication of H325. No alteration was found in the pmrA and other amino acid substitutions identified in the pmrB as well as lpx genes did not seem to be involved in colistin resistance as they were found in both ColS and ColR isolates. RT-qPCR analysis revealed a correlation between colistin resistance and pmrC overexpression. Specific alterations in the PmrB, linked to overproduction of PEtN transferase, triggered colistin resistance in the studied A. baumannii isolates.

Entities:  

Keywords:  Acinetobacter baumannii; PmrAB; PmrC; RT-qPCR; colistin resistance

Mesh:

Substances:

Year:  2018        PMID: 29590004     DOI: 10.1089/mdr.2017.0397

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  6 in total

1.  Overcoming addition of phosphoethanolamine to lipid A mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin-sulbactam combination therapy.

Authors:  Sukrit Srisakul; Paul G Higgins; Cameron Hurst; Parichart Hongsing; Sirirat Luk-In; Dhammika Leshan Wannigama; Shuichi Abe; Thammakorn Saethang; Tingting Liao; Naris Kueakulpattana; Aye Mya Sithu Shein; Lin Gan; Rosalyn Kupwiwat; Chanikan Tanasatitchai; Pattama Wapeesittipan; Phatthranit Phattharapornjaroen; Vishnu Nayak Badavath; Asada Leelahavanichkul; Tanittha Chatsuwan
Journal:  Sci Rep       Date:  2022-07-06       Impact factor: 4.996

2.  Frequency of Multi-Drug Resistance and Molecular Characteristics of Resistance to Colistin in Acinetobacter baumannii Collected from Patients in Intensive Care Units with Ventilator-Associated Pneumonia.

Authors:  Samaneh Babaei; Mihan Pourabdollah; Masoumeh Aslanimehr; Farhad Nikkhahi; Saeid Mahmoodian; Yasaman Hasani; Fatemeh Maryam Sheikholeslami
Journal:  Tanaffos       Date:  2021-04

Review 3.  Antibiotic resistance breakers: current approaches and future directions.

Authors:  Mark Laws; Ali Shaaban; Khondaker Miraz Rahman
Journal:  FEMS Microbiol Rev       Date:  2019-09-01       Impact factor: 16.408

4.  Survey on Genetic Diversity, Biofilm Formation, and Detection of Colistin Resistance Genes in Clinical Isolates of Acinetobacter baumannii.

Authors:  Saeed Khoshnood; Mohammad Savari; Effat Abbasi Montazeri; Ahmad Farajzadeh Sheikh
Journal:  Infect Drug Resist       Date:  2020-05-27       Impact factor: 4.003

5.  The threat of colistin resistance among carbapenem-resistant Klebsiella pneumoniae isolates in Iran.

Authors:  Mehri Haeili; Mohammad Mehdi Feizabadi
Journal:  Iran J Microbiol       Date:  2018-04

Review 6.  Understanding the Epidemiology of Multi-Drug Resistant Gram-Negative Bacilli in the Middle East Using a One Health Approach.

Authors:  Iman Dandachi; Amer Chaddad; Jason Hanna; Jessika Matta; Ziad Daoud
Journal:  Front Microbiol       Date:  2019-08-23       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.